New Zealand - English - Ministry for Primary Industries

zoetis new zealand limited - phenylbutazone - phenylbutazone 400 g/litre - analgesic

Canada - English - Health Canada

dominion veterinary laboratories ltd. - phenylbutazone (phenylbutazone sodium) - liquid - 200mg - phenylbutazone (phenylbutazone sodium) 200mg - horses; dogs

Canada - English - Health Canada

professional veterinary laboratories - phenylbutazone (phenylbutazone sodium) - liquid - 200mg - phenylbutazone (phenylbutazone sodium) 200mg - horses; dogs

Ireland - English - HPRA (Health Products Regulatory Authority)

dechra veterinary products a/s - phenylbutazone - oral powder - 1.0 g/sachet - phenylbutazone - non food-producing horses - n.s.a.i.d.

United States - English - NLM (National Library of Medicine)

covetrus north america - phenylbutazone (unii: gn5p7k3t8s) (phenylbutazone - unii:gn5p7k3t8s) - for relief of inflammatory conditions associated with the musculoskeletal system in horses. treated animals should not be slaughtered for food purposes. parenteral injections should be made intravenously only; do not inject subcutaneously or intramuscularly. use with caution in patients who have a history of drug allergy. for relief of inflammatory conditions associated with the musculoskeletal system in horses. intravenous dosage (not subcutaneous or intramuscular use) : horses : 1 to 2 g per 1,000 lb body weight (5 to 10 ml/1,000 lb) daily. not for use in horses intended for food. see package outsert for additional information. store in a refrigerator between 2o c and 8o c (36o f and 46o f).

United States - English - NLM (National Library of Medicine)

covetrus north america - phenylbutazone (unii: gn5p7k3t8s) (phenylbutazone - unii:gn5p7k3t8s) - indications: for the relief of inflammatory conditions associated with the musculoskeletal systems in horses. contraindications: use with caution in patients who have a history of drug allergy.

United States - English - NLM (National Library of Medicine)

bimeda, inc. - phenylbutazone (unii: gn5p7k3t8s) (phenylbutazone - unii:gn5p7k3t8s) - phenylbutazone 1 g in 3.027 g - actions and uses: kuzell (1,2,3), payne(4), flemming(5) and denko(6), demonstrated clinical effectiveness of phenylbutazone in acute rheumatism, gout, gouty arthritis and various other rheumatoid diseases in man. anti-inflammatory activity has been well established by fabre(7), domenjoz(8), wilhelmi(9), and yourish(10). lieberman(11) reported on the effective use of phenylbutazone in the treatment of conditions of the musculoskeletal system in dogs, including posterior paralysis associated with intervertebral disc syndrome, fractures, arthritis and injuries to the limbs and joints. joshua(12) observed objective improvement without toxicity following long-term therapy of two aged arthritic dogs. ogilvie and sutter(13) reported rapid response to phenylbutazone therapy in a review of 19 clinical cases including posterior paralysis, posterior weakness, arthritis, rheumatism and other conditions associated with lameness and musculoskeletal weakness. camberos(14) reported faborable results with phenylbutazone folow

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - phenylbutazone - oral tablet - 100mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - phenylbutazone - oral tablet - 200mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

essential generics ltd - phenylbutazone - oral tablet - 100mg